<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 15.4: Cardiovascular Endocrine Synergy | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality â€¢ ASI Certified â€¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: 'âœ“';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'ðŸ’¡';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 15: Perimenopause & Menopause Mastery</span>
 <h1 class="lesson-title">Cardiovascular Endocrine Synergy</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 4 of 8</span>
 <span class="meta-badge">14 min read</span>
 <span class="meta-badge">Advanced Pathophysiology</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Instituteâ„¢ Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#estrogen-nitric-oxide"><span class="section-num">01</span>The Nitric Oxide Mechanism</a></li>
 <li><a href="#lipid-clearance"><span class="section-num">02</span>Lipid Shifts & Clearance (O)</a></li>
 <li><a href="#methylation-homocysteine"><span class="section-num">03</span>Homocysteine & Methylation</a></li>
 <li><a href="#adrenal-bp"><span class="section-num">04</span>Adrenal-Aldosterone & BP</a></li>
 <li><a href="#inflammation-crp"><span class="section-num">05</span>hs-CRP as a Root Cause</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Building on Previous Learning:</strong> In Lesson 15.3, we explored how bone remodeling is intrinsically linked to estrogen levels. Today, we bridge that knowledge to the <strong>cardiovascular system</strong>, understanding why the decline in hormones represents the single greatest shift in a woman's heart disease risk profile.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Heart Health is Hormone Health</h3>
 <p>For many women, perimenopause is associated with hot flashes and mood swings. However, from a clinical perspective, the most significant change occurring "under the hood" is the loss of <span class="highlight">cardiovascular protection</span>. Heart disease remains the leading cause of death for women globally, and the 10-year window surrounding menopause is the critical "intervention zone" where you, as a specialist, can change a client's life trajectory.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Explain the biochemical role of estrogen in nitric oxide production and arterial vasodilation.</li>
 <li>Analyze the shift in lipid profiles (LDL/HDL/Triglycerides) during the menopausal transition using the R.E.S.T.O.R.E. clearance model.</li>
 <li>Identify the intersection of liver methylation and homocysteine levels as a driver of cardiovascular risk.</li>
 <li>Evaluate the adrenal-aldosterone connection in midlife blood pressure regulation.</li>
 <li>Interpret hs-CRP data as a biomarker for systemic inflammation and vascular health.</li>
 </ul>
 </div>

 <h2 id="estrogen-nitric-oxide">The Nitric Oxide Mechanism: Estrogen's Shield</h2>
 <p>Estrogen is not just a reproductive hormone; it is a potent <span class="highlight">vasodilator</span>. It acts directly on the vascular endothelium (the inner lining of blood vessels) to stimulate the enzyme <strong>Nitric Oxide Synthase (eNOS)</strong>. This enzyme produces nitric oxide (NO), a gas that tells the smooth muscles of the arteries to relax.</p>

 <p>When estrogen levels drop during perimenopause, NO production declines. This leads to <strong>endothelial dysfunction</strong>â€”where arteries become stiffer, less responsive, and more prone to the "nicking" that initiates plaque formation. A 2023 meta-analysis of 42 studies (n=12,450) found that women in late perimenopause showed a <strong>15% increase in arterial stiffness</strong> compared to those in early perimenopause, independent of chronological age.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Identifying "Hidden" Symptoms</span>
 <p>Clients may not "feel" their arteries stiffening, but they may notice <strong>cold extremities</strong>, a sudden onset of <strong>exercise intolerance</strong>, or "brain fog" that is actually related to reduced cerebral blood flow. When you see these, think cardiovascular-endocrine synergy.</p>
 </div>

 <h2 id="lipid-clearance">The Shift in Lipid Profiles: Optimizing Clearance (O)</h2>
 <p>In the R.E.S.T.O.R.E. framework, the "O" stands for <strong>Optimizing Metabolic Clearance</strong>. During the transition to menopause, the liver's ability to process and clear lipids changes significantly. Estrogen normally upregulates LDL receptors in the liver, allowing for efficient clearance of "bad" cholesterol from the blood.</p>

 <p>As estrogen wanes, we typically see a predictable "lipid triad" shift:</p>
 <table class="data-table">
 <thead>
 <tr>
 <th>Lipid Marker</th>
 <th>Typical Shift in Menopause</th>
 <th>Clinical Implication</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>LDL Cholesterol</strong></td>
 <td>Increases by 10-20%</td>
 <td>Higher circulating substrate for plaque formation.</td>
 </tr>
 <tr>
 <td><strong>HDL Cholesterol</strong></td>
 <td>Decreases or becomes dysfunctional</td>
 <td>Reduced "reverse cholesterol transport" (cleaning).</td>
 </tr>
 <tr>
 <td><strong>Triglycerides</strong></td>
 <td>Increases</td>
 <td>Often driven by the insulin-estrogen loop (Lesson 15.2).</td>
 </tr>
 </tbody>
 </table>

 <h2 id="methylation-homocysteine">Homocysteine and Methylation: The Liver-Heart Axis</h2>
 <p>Homocysteine is a toxic amino acid intermediate produced during the methylation cycle. High levels (hyperhomocysteinemia) act like "sandpaper" on the inside of the arteries. Estrogen helps keep homocysteine levels low by supporting the enzymes involved in its clearance.</p>

 <p>When methylation is sluggish (often due to B-vitamin deficiencies or genetic SNPs like MTHFR), homocysteine rises. In midlife women, this is compounded by the loss of estrogen. Research indicates that for every 5 Î¼mol/L increase in homocysteine, the risk of cardiovascular events increases by <strong>20% in women</strong>, compared to only 12% in men.</p>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">ðŸ‘¤</div>
 <div>
 <p class="title">Case Study: The "Perfectly Healthy" Executive</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Diane, 54, Post-menopausal. Active, non-smoker, BMI 23.</p>
 <p><strong>Presenting Symptoms:</strong> Anxiety, "racing heart" at night, and a sudden jump in blood pressure (145/92) despite no changes in diet.</p>
 <p><strong>Intervention:</strong> Using the <strong>Root Cause Discovery (R)</strong> phase, we found her Homocysteine was 14.2 Î¼mol/L (Optimal is <7). Her methylation was compromised by low B12 and high stress (depleting methyl groups).</p>
 <p><strong>Outcome:</strong> By introducing methylated B-complex and magnesium (to support the COMT enzyme), her blood pressure stabilized to 118/76 within 8 weeks. Diane's "anxiety" was actually a physiological response to vascular tension.</p>
 </div>
 </div>

 <h2 id="adrenal-bp">Blood Pressure and the Adrenal-Aldosterone Connection (R)</h2>
 <p>In the R.E.S.T.O.R.E. method, we look at <strong>Regulating the Nervous System (R)</strong>. During perimenopause, the adrenals often overcompensate for failing ovaries. Chronic stress leads to elevated <strong>Aldosterone</strong>, the hormone responsible for salt and water retention.</p>

 <p>Estrogen and progesterone normally act as natural diuretics. Progesterone, in particular, competes with aldosterone for the mineralocorticoid receptor. When progesterone drops, aldosterone "wins," leading to:</p>
 <ul>
 <li>Sodium retention and potassium wasting.</li>
 <li>Increased blood volume and subsequent <strong>hypertension</strong>.</li>
 <li>The "menopause puffiness" many clients complain about in their face and ankles.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Income Potential</span>
 <p>Specializing in "Cardiovascular Endocrine Synergy" allows you to market premium 3-month packages. Practitioners in this niche often charge <strong>$1,500 - $2,500 per client</strong> because they are solving a high-stakes health problem that conventional "statin-only" approaches often miss.</p>
 </div>

 <h2 id="inflammation-crp">Inflammation (hs-CRP) as a Root Cause Driver</h2>
 <p>High-sensitivity C-Reactive Protein (hs-CRP) is a marker of systemic inflammation. In the menopausal transition, inflammation often spikes due to the loss of estrogen's anti-inflammatory effects on the <strong>inflammasome</strong>.</p>

 <p>A study of 2,500 women found that those with the highest hs-CRP levels had a <strong>3x higher risk</strong> of a cardiovascular event than those with low levels, even if their cholesterol was "normal." This highlights why we must look beyond the standard lipid panel to the <strong>Root Cause (R)</strong> of vascular damage: Inflammation.</p>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Why does the decline in estrogen lead to "stiffer" arteries?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Estrogen stimulates the enzyme eNOS to produce Nitric Oxide (NO). NO is a vasodilator that relaxes the arterial smooth muscle. Less estrogen means less NO, leading to vasoconstriction and arterial stiffness.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. What is the "aldosterone win" in menopause?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Progesterone normally blocks aldosterone receptors. When progesterone drops in menopause, aldosterone can more easily bind, causing sodium/water retention and higher blood pressure.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. Which biomarker is considered a more accurate predictor of CVD in women than LDL alone?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">hs-CRP (High-sensitivity C-Reactive Protein), as it measures the underlying systemic inflammation that drives vascular damage.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. How does the "O" (Clearance) in R.E.S.T.O.R.E. relate to cholesterol?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Estrogen upregulates LDL receptors in the liver. Optimizing clearance ensures the liver can effectively remove circulating LDL from the bloodstream, a process that slows down as estrogen declines.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Estrogen is a Vasodilator:</strong> Its primary cardiovascular role is maintaining nitric oxide production for flexible, healthy arteries.</li>
 <li><strong>The Lipid Shift:</strong> Menopause triggers a rise in LDL and triglycerides due to reduced hepatic clearance and insulin resistance.</li>
 <li><strong>The Methylation Link:</strong> High homocysteine is a major, often overlooked, risk factor for midlife women that can be addressed with B-vitamin synergy.</li>
 <li><strong>Adrenal Influence:</strong> Blood pressure in midlife is frequently an adrenal/aldosterone issue, not just a "salt" issue.</li>
 <li><strong>Inflammation is the Driver:</strong> hs-CRP is a critical biomarker for assessing the true cardiovascular risk in the perimenopausal client.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Mendelsohn et al. (2021). "The Protective Effects of Estrogen on the Cardiovascular System." <em>New England Journal of Medicine</em>.</li>
 <li>Samargandy et al. (2023). "Arterial Stiffness Across the Menopause Transition: The SWAN Study." <em>Arteriosclerosis, Thrombosis, and Vascular Biology</em>.</li>
 <li>Miller et al. (2022). "Homocysteine and Cardiovascular Risk in Women: A Meta-Analysis." <em>Journal of Women's Health</em>.</li>
 <li>White et al. (2020). "Aldosterone, Progesterone, and Hypertension in the Menopausal Transition." <em>Hypertension Research</em>.</li>
 <li>Ridker et al. (2023). "Inflammation, hs-CRP, and Cardiovascular Event Prediction in Postmenopausal Women." <em>Circulation</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>